Literature DB >> 2557047

Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine.

M Carlsson1, A Carlsson.   

Abstract

The present study demonstrates that the muscarinic antagonist atropine and the alpha-adrenergic agonist clonidine, though ineffective when administered separately, produced a pronounced locomotor stimulation in monoamine-depleted mice when combined. The atropine + clonidine-induced locomotor stimulation was counteracted by both the alpha 2-adrenoceptor antagonist idazoxan and the acetylcholinesterase inhibitor physostigmine. Thus, it is clear that simultaneous manipulations with cholinergic and adrenergic systems are as effective in restoring locomotion in monoamine-depleted mice as increasing central dopaminergic tone. This finding may have implications for the treatment of a movement disorder like Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557047     DOI: 10.1007/BF02263486

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  8 in total

1.  Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice.

Authors:  A Svensson; M L Carlsson; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Restoration and putative protection in Parkinsonism.

Authors:  T Archer; A Fredriksson
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 3.  Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

Authors:  M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.

Authors:  M Carlsson; A Svensson; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

5.  The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.

Authors:  M P Hill; J M Brotchie
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

6.  Increased temporal patterns in choice responding and altered cognitive processes in schizophrenia and mania.

Authors:  Melvin Lyon; Aaron S Kemp
Journal:  Psychopharmacology (Berl)       Date:  2003-10-24       Impact factor: 4.530

7.  Extracts and constituents of Leontopodium alpinum enhance cholinergic transmission: brain ACh increasing and memory improving properties.

Authors:  Ariane Hornick; Stefan Schwaiger; Judith M Rollinger; Nguyen Phung Vo; Helmut Prast; Hermann Stuppner
Journal:  Biochem Pharmacol       Date:  2008-05-03       Impact factor: 5.858

8.  The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory.

Authors:  A Hornick; A Lieb; N P Vo; J M Rollinger; H Stuppner; H Prast
Journal:  Neuroscience       Date:  2011-09-10       Impact factor: 3.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.